CSIMarket
 


Invo Bioscience Inc   (INVO)
Other Ticker:  
 

Invo Bioscience Inc Profitability Comparisons

Select each Category to receive further Information


INVO Profitability Ratio

Company Industry Sector S&P 500
Gross Margin (Q3 MRQ) 53.63 % 49.56 % 48.52 % 45.68 %
Gross Margin (Q3 TTM) -86.2 % 49.89 % 49.61 % 45.26 %
Gross Margin 5 Yr. Avg. - 42.68 % 50.35 % 47.7 %
EBITDA Margin (Q3 MRQ) -1074.33 % 18.78 % 12.14 % 17.59 %
EBITDA Margin (Q3 TTM) -2917.03 % 16.64 % 12.62 % 18.43 %
EBITDA Margin 5 Yr. Avg. - 14.53 % 15.18 % 37.82 %
Operating Margin (Q3 MRQ) -1073.18 % 12.48 % 8.42 % 14.73 %
Operating Margin (Q3 TTM) -3211.34 % 10.44 % 10.04 % 15.5 %
Operating Margin 5 Yr. Avg. - 9.91 % 10.69 % 14.63 %
Pre-Tax Margin (Q3 MRQ) -1083.47 % 11.56 % 5.42 % 10.51 %
Pre-Tax Margin (Q3 TTM) -3278.43 % 9.36 % 5.9 % 11.42 %
Pre-Tax Margin 5 Yr. Avg. - 8.44 % 8.83 % 19.12 %
Net Margin (Q3 MRQ) -1083.47 % 9.33 % 4.31 % 8.3 %
Net Margin (Q3 TTM) -3279.11 % 7.62 % 4.52 % 9.19 %
Net Margin 5 Yr. Avg. - 7.29 % 7.03 % 15.07 %



Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q3 MRQ) -700.43 % 3.85 % 7.15 % 7.73 %
Free Cash Flow Margin (Q3 TTM) -6092.37 % - - -
Free Cash Flow Margin 5 Yr. Avg.